We invest the majority of our fund in Europe and the rest in the US. We bridge the continents for our portfolio companies, facilitating partnerships and building international networks to help everyone succeed.

 
 
 

GEOGRAPHY

Europe & United States

SECTORS

Specialty Pharma, Biopharmaceuticals, Medical Devices, Diagnostics

STAGE

From seed to public offerings

 
 
 

INVESTMENT CRITERIA

Potential for a strong exit within 4 to 6 years

FUNDS

€176M total; investments
of €7M to €10M

SYNDICATION

Will lead or co-lead an investment syndicate